We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Move is part of bloc’s effort to boost faltering immunisation programme
After suffering a breakdown, the acclaimed writer has found hope in new therapies
Emergency use authorisation could help identify ‘long Covid’ sufferers
Health secretary Matt Hancock praises NHS test and trace for ‘dogged determination’ in tracking individual down
Canberra urges Brussels to review Rome’s move while also expressing sympathy to EU
Recommendations from two FT roundtables with pharma, government, and NGO experts
U-turn could help speed up the country’s sluggish Covid-19 vaccination campaign
Intervention threatens to increase global tensions over procurement of Covid jabs
Decision makes approval possible in as little as two weeks after final data is received from manufacturers
Netcompany chief says health status apps are only a short-term solution as pandemic eases
WHO-backed report concludes that 9 out of 10 fatalities have occurred in countries with high obesity levels
Buyout group’s approach comes as private equity makes a push for healthcare deals amid pandemic
NHS funding set to fall as emergency Covid-19 support is scaled back
New York company co-founded by Joshua Kushner was valued at almost $8bn in flotation
Study finds PE management led to 10% increase in short-term mortality of Medicare patients
The more we destabilise the planet in the name of advancement, the more pathogens will emerge
Actions follow Biden administration warnings against rolling back pandemic rules too quickly
White House announces accelerated timeline after brokering production deal between J&J and Merck
Surveillance of AstraZeneca and Pfizer recipients in UK reports minor complaints but few severe reactions
UK research into LSD consumption reveals expectation of improved wellbeing drives transformation
With Europe facing a possible third wave and public doubts about efficacy, the commission president is under pressure from member states
Country lags far behind UK and US while jab strategy and technology underpinning it draw fierce criticism
Green energy supplier takes top spot and London remains the city with the most high-growth businesses
New data bring about policy shift as other EU countries likely to abandon age limits
International Edition
